We develop bioprinting solutions for regenerative medicine and advanced tissue engineering. Our lead program focuses on in-vivo printing for urinary bladder repair, where we have completed preclinical studies and are advancing into clinical trials.

​

Beyond this, we work with high-precision droplet bioprinting for research applications, and with spheroids, organoids, and scaffold-based constructs, including collaborative projects such as engineered liver tissue. Across these areas, our platform enables accurate and reproducible cellular placement to support novel therapeutic pathways.